How Early Raw Material Testing Mitigates Product Development & Regulatory Risk

January 31, 2024

1 Min Read
Courtesy of Secant Group

In early medical device product development, analytical testing of raw material commonly is viewed as more of a luxury than a necessity. However, early analytical testing offers medical device manufacturers the opportunity to produce more robust data to proactively mitigate risks to be better prepared for the regulatory submission process. This approach enables time and cost savings while contributing to a higher-quality final product.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like